What lipoprotein fraction accumulates in familial beta hyperlipoproteinemia?

What lipoprotein fraction accumulates in familial beta hyperlipoproteinemia?

• A. Chylomicrons
• B. Very Low-Density Lipoprotein (V.L.D.L)
• C. Intermediate Density Lipoprotein (I.D.L)
• D. High-Density Lipoprotein (H.D.L)

Answer: (C)

Familial beta hyperlipoproteinemia, also known as familial dysbetalipoproteinemia, is characterized by an accumulation of Intermediate Density Lipoprotein (IDL). This condition is caused by genetic mutations that affect the metabolism of lipoproteins, specifically leading to the ineffective clearance of IDL from the bloodstream. In terms of lipoprotein metabolism, IDL is formed during the conversion of VLDL to LDL. Individuals with familial beta hyperlipoproteinemia exhibit elevated levels of IDL due to impaired processing and removal of these lipoproteins. As a result, the buildup of IDL can contribute to atherosclerosis and other cardiovascular issues. Understanding the role of lipoproteins in lipid metabolism is crucial in clinical diagnostics and management of hyperlipidemic disorders. This knowledge allows for targeted therapies and lifestyle modifications aimed at reducing the health risks associated with lipid imbalances.

Familial beta hyperlipoproteinemia, also known as familial dysbetalipoproteinemia, is characterized by an accumulation of Intermediate Density Lipoprotein (IDL). This condition is caused by genetic mutations that affect the metabolism of lipoproteins, specifically leading to the ineffective clearance of IDL from the bloodstream.

In terms of lipoprotein metabolism, IDL is formed during the conversion of VLDL to LDL. Individuals with familial beta hyperlipoproteinemia exhibit elevated levels of IDL due to impaired processing and removal of these lipoproteins. As a result, the buildup of IDL can contribute to atherosclerosis and other cardiovascular issues.

Understanding the role of lipoproteins in lipid metabolism is crucial in clinical diagnostics and management of hyperlipidemic disorders. This knowledge allows for targeted therapies and lifestyle modifications aimed at reducing the health risks associated with lipid imbalances.